Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Propecia®:MSD Merck Sharp & Dohme AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
D11AX10 - FinasterideATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D11 - Other Dermatological Preparations
D11A - Other Dermatological Preparations

This group comprises various dermatological preparations, which cannot be classified in the preceding groups.
Insect repellents are classified in P03B - Insecticides and repellents.

D11AX - Other Dermatologicals

This group comprises products, which cannot be classified in the preceding groups. E.g. minoxidil for the treatment of male pattern baldness is classified here.
Lithium succinate in combination with other substances, e. g. zinc sulphate is classified in D11AX04 - lithium succinate.
Diclofenac formulated as a 3% hyaluronic acid gel used in treatment of actinic keratoses is classified here.
Hydrogenperoxide =40% solutions used in the treatment of seborrheic keratosis or warts are classified here, while low strength solutions are classified in D08AX.

D11AX10 - Finasteride
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home